2-(Arylmethyl)-3-substituted quinuclidines as selective α7 nicotinic receptor ligands

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2005-04-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2005.02.045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects.

  2006cited by this paper
• Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity.

  2004cited by this paper
• AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors

  2004cited by this paper
• The Neuroprotective Effect of 2-(3-Pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a Novel α7 Ligand, Is Prevented through Angiotensin II Activation of a Tyrosine Phosphatase

  2004cited by this paper
• Neuronal nicotinic acetylcholine receptor agonists

  2004cited by this paper
• Targeting neuronal nicotinic receptors: a path to new therapies.

  2002cited by this paper
• Chapter 5. Targeting nicotinic acetylcholine receptors: Advances in molecular design and therapies

  2000cited by this paper
• The Activation and Inhibition of Human Nicotinic Acetylcholine Receptor by RJR‐2403 Indicate a Selectivity for the α4β2 Receptor Subtype

  2000cited by this paper
• Exploring the nature of molecular recognition in nicotinic acetylcholine receptors.

  2000cited by this paper
• TC-2559: a novel orally active ligand selective at neuronal acetylcholine receptors.

  2000cited by this paper
• (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor.

  2000cited by this paper
• Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors.

  1999cited by this paper
• The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes.

  1998cited by this paper
• Selective muscarinic antagonists. II. Synthesis and antimuscarinic properties of biphenylylcarbamate derivatives.

  1998cited by this paper
• 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.

  1998cited by this paper
• RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.

  1996cited by this paper
• Identification of a series of 3-(benzyloxy)-1-azabicyclo[2.2.2]octane human NK1 antagonists.

  1995cited by this paper
• Synthesis of a benzo[b]-1,5-naphthyridine derivative as a potential constrained NK1 receptor antagonist

  1994cited by this paper
• Derivatives of quinuclidine as 5-HT3 receptor antagonists: influence of an additional carbonyl group on the recognition of chirality by the receptor.

  1993cited by this paper
• [3-Aminoquinuclidine carbamates, ureas, thio-ureas derivatives with potential parasiticidal activity (author's transl)].

  1980cited by this paper
• Quinuclidine chemistry. 4. Diuretic properties of cis-3-amino-2-benzhydrylquinuclidine.

  1975cited by this paper
• Quinuclidine chemistry. 2. Synthesis and antiinflammatory properties of 2-substituted benzhydryl-3-quinuclidinols.

  1974cited by this paper
• Quinuclidine chemistry. I. Configuration and chemistry of 2-substituted benzylidene-3-quinuclidinones

  1974cited by this paper

• Dual Cholinergic Modulation in Dementia: Quinuclidine Carbamates Targeting Butyrylcholinesterase and α7 Nicotinic Receptor.

  2025cites this paper
• Ruthenium-Catalyzed Highly Enantioselective Synthesis of cis-3-Quinuclidinols via DKR Asymmetric Transfer Hydrogenation.

  2020cites this paper
• Organic Chemistry: An Indian Journal

  2018influential citation
• Neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease

  2017cites this paper
• Synthesis and Pharmacological Evaluation of Novel Pyrazolyl Piperidine Derivatives as Effective Antiplatelet Agents: Synthesis and Pharmacological Evaluation of Novel Pyrazolyl Piperidine Derivatives as Effective Antiplatelet Agents

  2017cites this paper
• The alpha 7, alpha 4 beta 2 and alpha 3 beta 4 Nicotinic Acetylcholine Receptors: Characteristics, Role in Pathogenic Processes and Bioactive Compounds

  2016cites this paper
• Synthesis of Quinuclidines by Intramolecular Silver-Catalysed Amine Additions to Alkynes

  2014cites this paper
• Discovery of novel 2-((pyridin-3-yloxy)methyl)piperazines as α7 nicotinic acetylcholine receptor modulators for the treatment of inflammatory disorders.

  2014cites this paper
• Virtual screening for alpha7 nicotinic acetylcholine receptor for treatment of Alzheimer's disease.

  2013cites this paper
• Impact of Solid-Supported Cyclization–Elimination Strategies toward the Development of Natural Product Inspired Molecules in Drug Discovery Research*

  2013cites this paper
• 3D Molecular Descriptors Important for Clinical Success

  2013cites this paper
• Molecular Imaging of 7 Nicotinic Acetylcholine Receptors In Vivo: Current Status and Perspectives

  2012cites this paper
• Diazaspirocyclic compounds as selective ligands for the α4β2 nicotinic acetylcholine receptor.

  2012cites this paper
• Perspectives on the Synthesis of Organic Carbamates

  2012cites this paper
• Discovery of (2S,3R)-N-[2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]benzo[b]furan-2-carboxamide (TC-5619), a selective α7 nicotinic acetylcholine receptor agonist, for the treatment of cognitive disorders.

  2012cites this paper
• Discovery and development of α7 nicotinic acetylcholine receptor modulators.

  2011cites this paper
• Interaction kinetic and structural dynamic analysis of ligand binding to acetylcholine-binding protein.

  2010cites this paper
• α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease

  2010cites this paper
• Structure-activity relationships of N-substituted ligands for the alpha7 nicotinic acetylcholine receptor.

  2010cites this paper
• Neuroinflammation in Parkinson's disease: a target for neuroprotection?

  2009cites this paper
• TRAITEMENT AVEC DES LIGANDS SÉLECTIFS DU RÉCEPTEUR α7

  2009cites this paper
• Parallel synthesis of a series of potentially brain penetrant aminoalkyl benzoimidazoles.

  2008cites this paper
• Central Nicotinic Receptors: Structure, Function, Ligands, and Therapeutic Potential

  2007cites this paper
• The quest for the treatment of cognitive impairment: α7 nicotinic and α5 GABAA receptor modulators

  2007cites this paper
• Synthesis and positron emission tomography studies of radioligands targeting alpha7 nicotinic acetylcholine receptors in the central nervous system

  2007cites this paper
• Aryloxyethylamines: Binding at α7 nicotinic acetylcholine receptors

  2006cites this paper
• Neuronal Nicotinic Acetylcholine Receptor Modulators: Recent Advances and Therapeutic Potential

  2005cites this paper